EUVIMEDEUVIMED entdecken
Crossref

DON encapsulated carbon dot–vesicle conjugate in therapeutic intervention of lung adenocarcinoma by dual targeting of CD44 and SLC1A5

Afreen Zaman, Aparajita Ghosh, Anup Kumar Ghosh, Prasanta Kumar Das

Nanoscale · 2024 · 16 (47) · 21817-21836

DOI: 10.1039/d4nr00426d ↗

Kurz gefasst

Fachartikel in der Zeitschrift Nanoscale, 2024. Verfasst von Afreen Zaman und 3 weiteren Autor:innen. Beteiligte Einrichtung: School of Biological Sciences, Indian Association for the Cultivation of Science, Jadavpur, Kolkata - 700032, India. bcpkd@iacs.res.in. Hauptthemen laut MEDLINE: Hyaluronan Receptors, Lung Neoplasms, Adenocarcinoma of Lung, Carbon. Die Arbeit wurde bisher 11-mal zitiert (Crossref) und nennt 62 Literaturangaben. Gefördert von: Science and Engineering Research Board, DST.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

HACD–TMAV, a carbon dot–vesicle conjugate, selectively delivered glutamine inhibitor DON to CD44-enriched cancer cells, inducing ROS triggered apoptosis by dual targeting CD44 and SLC1A5 through downregulation of PI3K/AKT/mTOR signalling cascade.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Hyaluronan ReceptorsLung NeoplasmsAdenocarcinoma of LungCarbonHumansA549 CellsHEK293 CellsHyaluronic AcidHep G2 CellsQuantum DotsCell SurvivalAntineoplastic AgentsReactive Oxygen SpeciesApoptosisMinor Histocompatibility AntigensAmino Acid Transport System ASC

Substanzen

Hyaluronan ReceptorsCD44 protein, humanCarbonSLC1A5 protein, humanHyaluronic AcidAntineoplastic AgentsReactive Oxygen SpeciesMinor Histocompatibility AntigensAmino Acid Transport System ASC

Autor:innen und Institutionen

  • School of Biological Sciences, Indian Association for the Cultivation of Science, Jadavpur, Kolkata - 700032, India. bcpkd@iacs.res.in.

Förderung

  • Science and Engineering Research Board, DST

Zitieren

APA

Zaman, A., Ghosh, A., Ghosh, A. K., & Das, P. K. (2024). DON encapsulated carbon dot–vesicle conjugate in therapeutic intervention of lung adenocarcinoma by dual targeting of CD44 and SLC1A5. Nanoscale, 16(47), 21817-21836. https://doi.org/10.1039/d4nr00426d

Vancouver

Zaman A, Ghosh A, Ghosh AK, Das PK. DON encapsulated carbon dot–vesicle conjugate in therapeutic intervention of lung adenocarcinoma by dual targeting of CD44 and SLC1A5. Nanoscale. 2024;16(47):21817-21836. doi:10.1039/d4nr00426d

BibTeX
@article{Zaman2024,
  author = {Zaman, Afreen and Ghosh, Aparajita and Ghosh, Anup Kumar and Das, Prasanta Kumar},
  title = {DON encapsulated carbon dot–vesicle conjugate in therapeutic intervention of lung adenocarcinoma by dual targeting of CD44 and SLC1A5},
  journal = {Nanoscale},
  year = {2024},
  volume = {16},
  number = {47},
  pages = {21817--21836},
  doi = {10.1039/d4nr00426d}
}
Kostenlos starten →